TABLE 2.
Proportion of resistance among the 323 ESC-resistant Enterobacterales isolates
| Antibiotics | E. coli (n = 283) | Klebsiella sp. (n = 28) | Enterobacter cloacae (n = 7) | Proteus mirabilis (n = 5) |
|---|---|---|---|---|
| Amoxicillin-clavulanate | 253 (88.8%) | 26 (93.1%) | 7 (100%) | 3 (60%) |
| Cefoxitin | 117 (41.1%) | 7 (25%) | 0 (0%) | 0 (0%) |
| Cefotaxime | 283 (100%) | 28 (100%) | 7 (100%) | 5 (100%) |
| Ceftazidime | 273 (95.8%) | 26 (93.1%) | 7 (100%) | 3 (60%) |
| Cefepime | 201 (70.5%) | 23 (79.3%) | 6 (85.7%) | 3 (60%) |
| Aztreonam | 239 (83.9%) | 23 (79.3%) | 7 (100%) | 3 (60%) |
| Imipenem | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Ertapenem | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Gentamicin | 266 (93.3%) | 28 (100%) | 3 (42.8%) | 5 (100%) |
| Ciprofloxacin | 280 (98.2%) | 28 (100%) | 7 (100%) | 5 (100%) |
| Trimethoprim Sulfamethoxazole | 253 (88.8%) | 28 (100%) | 7 (100%) | 5 (100%) |
| Tetracyclines | 283 (100%) | 28 (100%) | 7 (100%) | 5 (100%) |
| Amikacin | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |